- Home
- POLA vs AIMD Comparison
POLA vs AIMD Comparison
Compare POLA & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- AIMD
- Stock Information
- Founded
- POLA 1979
- AIMD 1984
- Country
- POLA United States
- AIMD United States
- Employees
- POLA N/A
- AIMD N/A
- Industry
- POLA Industrial Machinery/Components
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- AIMD Health Care
- Exchange
- POLA Nasdaq
- AIMD Nasdaq
- Market Cap
- POLA 8.3M
- AIMD 7.5M
- IPO Year
- POLA 2016
- AIMD N/A
- Fundamental
- Price
- POLA $2.09
- AIMD $0.54
- Analyst Decision
- POLA
- AIMD
- Analyst Count
- POLA 0
- AIMD 0
- Target Price
- POLA N/A
- AIMD N/A
- AVG Volume (30 Days)
- POLA 63.9K
- AIMD 154.6K
- Earning Date
- POLA 05-14-2025
- AIMD 03-07-2025
- Dividend Yield
- POLA N/A
- AIMD N/A
- EPS Growth
- POLA N/A
- AIMD N/A
- EPS
- POLA N/A
- AIMD N/A
- Revenue
- POLA $13,970,000.00
- AIMD $20,729.00
- Revenue This Year
- POLA N/A
- AIMD N/A
- Revenue Next Year
- POLA N/A
- AIMD N/A
- P/E Ratio
- POLA N/A
- AIMD N/A
- Revenue Growth
- POLA N/A
- AIMD N/A
- 52 Week Low
- POLA $1.78
- AIMD $0.40
- 52 Week High
- POLA $4.90
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- POLA 31.27
- AIMD 51.16
- Support Level
- POLA $2.30
- AIMD $0.46
- Resistance Level
- POLA $2.54
- AIMD $0.57
- Average True Range (ATR)
- POLA 0.17
- AIMD 0.05
- MACD
- POLA -0.04
- AIMD 0.00
- Stochastic Oscillator
- POLA 0.00
- AIMD 69.03
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.